The GOALS framework streamlines sexual history taking to enhance the patient-clinician relationship and elicit information most useful for identifying an appropriate clinical course of action, such as screening, testing, and education.
Use of Doxy-PEP
Management of Syphilis, Gonorrhea, and Chlamydia in Patients With HIV
Please refer to CDC > Sexually Transmitted Infections Treatment Guidelines, 2021
- Purpose of This Guideline
- PrEP for Individuals at Risk of Acquiring HIV
- Choosing and Prescribing a PrEP Regimen
- Laboratory Testing Before PrEP Initiation
- Ongoing Laboratory Testing
- Managing a Positive HIV Test Result
- Discontinuing PrEP
- Appendix: Care Provider Checklists for PrEP Initiation, Regimen Choice, and Follow-Up
- All Recommendations
- Guideline Information
- Purpose of This Guideline
- Considerations and Contraindications
- COVID-19
- Haemophilus influenzae Type B (Hib)
- Hepatitis A Virus (HAV)
- Hepatitis B Virus (HBV)
- Human Papillomavirus (HPV)
- Influenza
- Measles, Mumps, Rubella (MMR)
- Meningococcal Serotypes A,C, W, and Y (MenACWY)
- Meningococcal Serotype B (MenB)
- Mpox
- Pneumococcal
- Tetanus, Diphtheria, and Pertussis (Tdap) and Tetanus-Diphtheria (Td)
- Varicella
- Zoster
- All Recommendations
- Guideline Information and Updates
- Purpose of This Guideline
- Definition of Terms
- Goals of Screening and Risk Assessment
- Substance Use Screening for All Adult Patients in the Primary Care Setting
- Screening Tools
- Risk Assessment
- Management of Low-, Moderate-, and High-Risk Substance Use
- Diagnosis of Substance Use Disorder
- All Recommendations
- Guideline Information